Treatment of organ transplant-related lymphoma

Hematology/Oncology Clinics of North America

Volumn 11, Issue 5, 1997, Pages 963-973

  Swinnen, L J ^a  

^a Building 112   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; METHOTREXATE; PREDNISONE; VINCRISTINE;

DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE PREDISPOSITION; EPSTEIN BARR VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LYMPHOPROLIFERATIVE DISEASE; NONHODGKIN LYMPHOMA; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; VIRUS CARCINOGENESIS;

EID: 0030886756     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70473-1     Document Type: Article

References (42)

1. J.M. Armitage F.J. Fricker P. del Nido A decade (1982 to 1992) of pediatric cardiac transplantation and the impact of FK 506 immunosuppression J Thorac Cardiovasc Surg 105 1993 464 472
2. J.M. Armitage R.L. Kormos R.S. Stuart Posttransplant lymphoproliferative disease in thoracic organ transplant patients: Ten years of cyclosporine-based immunosuppression J Heart Lung Transplant 10 1991 877 886
3. J.F. Bach L. Chatenoud Immunologic monitoring of Orthoclone OKT3-treated patients: The problem of antimonoclonal immune response Transplant Proc 19 1987 17 20
4. T. Beveridge P. Krupp C. McKibbin Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy [letter] Lancet 1 1984 788
5. M.E. Billingham J.W. Mason M.R. Bristow J.R. Daniels Anthracycline cardiomyopathy monitored by morphologic changes Cancer Treat Rep 62 1978 865 872
6. H. Cen P.A. Williams H.P. McWilliams Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with post-transplant lymphoproliferative disorders Blood 81 1993 1393 1403
7. M.L. Cleary R. Warnke J. Sklar Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients. Clonal analysis based on immunoglobulin-gene rearrangements N Engl J Med 310 1984 477 482
8. D.G. Deschler R. Osorio N.L. Ascher K.C. Lee Posttransplantation lymphoproliferative disorder in patients under primary tacrolimus (FK 506) immunosuppression [review] Arch Otolaryngol Head Neck Surg 121 1995 1037 1041
9. A.H. Filipovich A. Mathur D. Kamat Lymphoproliferative disorders and other tumors complicating immunodeficiencies [review] Immunodeficiency 5 1994 91 112
10. A. Fischer S. Blanche J. Le Bidois Anti–B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation N Engl J Med 324 1991 1451 1456
11. G. Frizzera D.W. Hanto K.J. Gajl-Peczalska Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients Cancer Res 41 1981 4262 4279
12. M.N. Hanson V.A. Morrison B.A. Peterson Posttransplant T-cell lymphoproliferative disorders—an aggressive, late complication of solid-organ transplantation Blood 88 1996 3626 3633
13. D.W. Hanto M. Birkenbach G. Frizzera Confirmation of the heterogeneity of posttransplant Epstein-Barr virus–associated B cell proliferations by immunoglobulin gene rearrangement analyses Transplantation 47 1989 458 464
14. D.W. Hanto G. Frizzera K.J. Gajl-Peczalska Epstein-Barr virus–induced B-cell lymphoma after renal transplantation: Acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation N Engl J Med 306 1982 913 918
15. D.W. Hanto G. Frizzera D.T. Purtilo Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus Cancer Res 41 1981 4253 4261
16. M. Ho R. Jaffe G. Miller The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children Transplantation 45 1988 719 727
17. G. Klein Lymphoma development in mice and humans: Diversity of initiation is followed by convergent cytogenetic evolution Proc Nat Acad Sci USA 76 1979 2442 2446
18. D.M. Knowles E. Cesarman A. Chadburn Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders Blood 85 1995 552 565
19. V. Leblond L. Sutton R. Dorent Lymphoproliferative disorders after organ transplantation: A report of 24 cases observed in a single center J Clin Oncol 13 1995 961 968
20. V.A. Morrison D.L. Dunn J.C. Manivel Clinical characteristics of post-transplant lymphoproliferative disorders Am J Med 97 1994 14 24
21. P.G. Murray L.J. Swinnen C.M. Constandinou bcl-2 but not its Epstein-Barr virus–encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disorders [see comments] Blood 87 1996 706 711
22. M.A. Nalesnik R. Jaffe T.E. Starzl The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A–prednisone immunosuppression Am J Pathol 133 1988 173 192
23. M.A. Nalesnik J. Locker R. Jaffe Clonal characteristics of posttransplant lymphoproliferative disorders Transplant Proc 20 1988 280 283
24. M.A. Nalesnik L. Makowka T.E. Starzl The diagnosis and treatment of posttransplant lymphoproliferative disorders Curr Probl Surg 25 1988 367 472
25. G. Opelz R. Henderson Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients [see comments] Lancet 342 1993 1514 1516
26. E.B. Papadopoulos M. Ladanyi D. Emanuel Infusions of donor leukocytes to treat Epstein-Barr virus–associated lymphoproliferative disorders after allogeneic bone marrow transplantation [see comments] N Engl J Med 330 1994 1185 1191
27. D.T. Purtilo Epstein-Barr-virus–induced oncogenesis in immune-deficient individuals Lancet 1 1980 300 303
28. P.S. Randhawa R. Jaffe A.J. Demetris Expression of Epstein-Barr virus–encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease [see comments] N Engl J Med 327 1992 1710 1714
29. D. Rea C. Fourcade V. Leblond Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation Transplantation 58 1994 317 324
30. S.A. Riddler M.C. Breinig J.L. McKnight Increased levels of circulating Epstein-Barr virus (EBV)–infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients Blood 84 1994 972 984
31. C.M. Rooney S.K. Loftin M.S. Holladay Early identification of Epstein-Barr virus–associated post-transplantation lymphoproliferative disease Br J Haematol 89 1995 98 103
32. C.M. Rooney C.A. Smith C.Y. Ng Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus–related lymphoproliferation Lancet 345 1995 9 13
33. R.S. Shapiro A. Chauvenet W. McGuire Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin [letter] N Engl J Med 318 1988 1334
34. R.S. Shapiro K. McClain G. Frizzera Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation Blood 71 1988 1234 1243
35. T.E. Starzl M.A. Nalesnik K.A. Porter Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy Lancet 1 1984 583 587
36. L.J. Swinnen M.R. Costanzo-Nordin S.G. Fisher Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients N Engl J Med 323 1990 1723 1728
37. L.J. Swinnen G.M. Mullen T.J. Carr Aggressive treatment for postcardiac transplant lymphoproliferation Blood 86 1995 3333 3340
38. R.C. Walker W.F. Marshall J.G. Strickler Pretransplantation assessment of the risk of lymphoproliferative disorder Clin Infect Dis 20 1995 1346 1353
39. R.C. Walker C.V. Paya W.F. Marshall Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations J Heart Lung Transplant 14 1995 214 221
40. R.P. Witherspoon L.D. Fisher G. Schoch Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia [see comments] N Engl J Med 321 1989 784 789
41. L. Young C. Alfieri K. Hennessy Expression of Epstein-Barr virus transformation–associated genes in tissues of patients with EBV lymphoproliferative disease N Engl J Med 321 1989 1080 1085
42. M.M. Zutter P.J. Martin G.E. Sale Epstein-Barr virus lymphoproliferation after bone marrow transplantation Blood 72 1988 520 529